[Intratympanic dexamethasone injections for intractable Meniere's disease].
OBJECTIVE
To investigate the efficacy of intratympanic dexamethasone injections (IDI) and intermittent pressure (IP) for 13 patients with intractable Meniere's disease (MD).


METHODS
Dexamethasone (5 g/L) was injected into the middle ear. The injection was repeated the next day and weekly for 3 weeks. Together with tympanic intermittent pressure (IP).


RESULTS
The 13 patients was followed up for 2-5 years. Complete relief vertigo was maintained in 9 cases,improved in 3 cases. The injection was repeated in 1 patient with recurrent vertigo and total control of vertigo was obtained. Tinnitus disappeared in 5 cases, reduced in 3 case, unchanged in 5 cases. Hearing was improved in 9 cases, unchanged in 4 cases.


CONCLUSIONS
IDI and IP are effective for intractable MD. The benefits of IDI and IP are easy application for doctors and reasonable cost which can be accepted by patients easily.
Huang
Ying
Y
Department of Otolaryngology-Head and Neck Surgery, the Hospital of Luzhou Medical College, Luzhou, 646000, China. hy11485@sohu.com
She
Yu
Y
Li
Wanrong
W
Cheng
Chongyi
C
D000328:Adult; D003907:Dexamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D004432:Ear, Middle; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D008875:Middle Aged; D016896:Treatment Outcome
D003907:Dexamethasone